Thermo Fisher Scientific Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/01/2023
Thermo Fisher Scientific Inc Stock Forecast and Price Target
Thermo Fisher Scientific Inc's stock price reaches the average target of $620.00 by 2024 as expected recently by four notable experts, there would be a potential upside of approximately 7.56% from the last closing price in March, 2023. This possible increase is based on a high estimate of $690.00 and a low estimate of $505.00. If you want to buy TMO stock, it might be a good idea to look at its competitors too.
7.56% Upside
Thermo Fisher Scientific Inc Fair Value Forecast for 2023 - 2025 - 2030
Thermo Fisher Scientific Inc's Price has grown in the last three years, jumping from $306.90 to $441.09 – an increase of 43.72%. In the next year, analysts predict that Fair Value will reach $603.36 – an increase of 36.79%. For the next eight years, the forecast is for Fair Value to grow by 97.55%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$252.04 | Buy/Sell | $304.24 | 20.81% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$138.34 | Buy/Sell | $162.50 | 20.36% |
| ILMN Stock Forecast | Illumina Inc | Outperform |
16
|
$232.55 | Buy/Sell | $254.08 | 7.29% |
| MTD Stock Forecast | Mettler-Toledo International I... | Hold |
13
|
$1.53k | Buy/Sell | $1.39k | -10.77% |
| WAT Stock Forecast | Waters Corp | Hold |
15
|
$309.62 | Buy/Sell | $336.44 | 9.81% |
Thermo Fisher Scientific Inc Revenue Forecast for 2023 - 2025 - 2030
Thermo Fisher Scientific Inc's Revenue has grown in the last three years, jumping from $25.54B to $44.92B – an increase of 75.85%. In the next year, 18 analysts estimate that Thermo Fisher Scientific Inc's Revenue will decrease by 1.03%, reaching $44.45B. For the next eight years, the forecast is for Revenue to grow by 22.38%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$133.27 | Buy/Sell | $159.83 | 21.93% |
| AVTR Stock Forecast | Avantor | Buy |
16
|
$21.13 | Buy/Sell | $0.00 | 112.97% |
| BIO Stock Forecast | Bio-Rad Laboratories | Buy |
16
|
$479.02 | Buy/Sell | $606.00 | 21.60% |
.jpg)
Thermo Fisher Scientific Inc Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Thermo Fisher Scientific Inc's Dividend per Share has increased by 84.21%, going from $0.76 to $1.40. According to 10 analysts, Thermo Fisher Scientific Inc's Dividend per Share will fall by 16.43% in the next year, reaching $1.17. The Thermo Fisher Scientific Inc forecast is for Dividend per Share to reach $1.45 or grow by 3.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRKR Stock Forecast | Bruker Corp | Outperform |
16
|
$78.82 | Buy/Sell | $72.11 | -4.85% |
| COHR Stock Forecast | Coherent | Hold |
12
|
$266.22 | Buy/Sell | $255.33 | 7.95% |
| PACB Stock Forecast | Pacific Biosciences of Califor... | Outperform |
9
|
$11.57 | Buy/Sell | $17.33 | 42.61% |
Thermo Fisher Scientific Inc Free Cash Flow Forecast for 2023 - 2025 - 2030
Thermo Fisher Scientific Inc's Free Cash Flow has increased by 170718951.15% In the last three years, going from $4.05B to $6909.00T. 6 analysts predict Thermo Fisher Scientific Inc's Free Cash Flow will decrease by 100.00% in the next year, reaching $7.98B. By 2030, professionals predict that Thermo Fisher Scientific Inc's Free Cash Flow will decrease by 100.00%, to $9.63B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FLDM Stock Forecast | Fluidigm | - |
11
|
$20.44 | Buy/Sell | $12.00 | -91.34% |
| HBIO Stock Forecast | Harvard Bioscience | Buy |
14
|
$3.10 | Buy/Sell | $10.00 | 222.58% |
| EQTL Stock Forecast | Equitech International | - |
0
|
$2.00 | Buy/Sell | $0.00 | -100.00% |
Thermo Fisher Scientific Inc Net Income Forecast for 2023 - 2025 - 2030
In the last three years, Thermo Fisher Scientific Inc's Net Income has grown, increasing from $3.70B to $6.96B – an increase of 88.31%. For next year, the 16 analysts predict Net Income of $9.45B, which would mean an increase of 35.78%. Over the next eight years, the pros' prediction is Net Incomeof $12.85B, which would mean a eight-year growth forecast of 84.61%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OMRX Stock Forecast | Orthometrix | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| LFPI Stock Forecast | LifePoint | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| MDIT Stock Forecast | Medite Cancer Diagnostics | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Thermo Fisher Scientific Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Thermo Fisher Scientific Inc's EBITDA has grown, increasing from $6.54B to $12.06B – a growth of 84.37%. The next year looks promising for Thermo Fisher Scientific Inc, with analysts predicting EBITDA of $12.38B – an increase of 2.71%. Over the next eight years, experts anticipate that Thermo Fisher Scientific Inc's EBITDA will grow at a rate of 22.78%.
Thermo Fisher Scientific Inc EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Thermo Fisher Scientific Inc's EBIT has grown by 139.98%, from $4.26B to $10.23B. For the next year, analysts are expecting EBIT to reach $11.31B – an increase of 10.56%. Over the next eight years, experts predict that EBIT will grow by 52.29%.
Thermo Fisher Scientific Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
Thermo Fisher Scientific Inc's EPS has grown in the last three years, jumping from $12.35 to $17.75 – an increase of 43.72%. In the next year, analysts predict that EPS will reach $24.28 – an increase of 36.79%. For the next eight years, the forecast is for EPS to grow by 97.55%.
Site Navigation
.jpg)